Intracystic injection of pingyangmycin(PYM) might be a more favorable option for treatment of oral and plunging ranulas  

作　　者：YANG Xiu-juan ZHENG Jia-wei ZHOU Qin ZHANG Shan-yong YANG Chi 

机构地区：[1]Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, College of Stomatology,Shanghai Jiao Tong University School of Medicine. Shanghai 200011, China

出　　处：《上海口腔医学》2010年第4期447-448,共2页Shanghai Journal of Stomatology

摘　　要：Ranulas are mucoceles that develop as a result of mucous extravasation from the sublingual gland and typically present in the floor of mouth. The treatment of ranulas are various, mainly including surgical and nonsurgical methods. The preferred treatment of oral and plunging ranulas is still uncertain. According to the complications associated with surgical therapy, nonsurgical sclerotherapy has been advocated by clinicians for its advantages of less injury, no scar,less suffering, etc. Recently, it was reported that OK-432 was a relatively effective sclerosing agent for both lymphatic malformations and ranulas, although it has a high rate of recurrence after treating ranulas. Pingyangmycin is another reported conventional sclerosing agent for lymphatic malformations. Herein, we hypothesize that intracystic injection of pingyangmycin may be an optimal method for the treatment of ranulas.Ranulas are mucoceles that develop as a result of mucous extravasation from the sublingual gland and typically present in the floor of mouth. The treatment of ranulas are various, mainly including surgical and nonsurgical methods. The preferred treatment of oral and plunging ranulas is still uncertain. According to the complications associated with surgical therapy, nonsurgical sclerotherapy has been advocated by clinicians for its advantages of less injury, no scar,less suffering, etc. Recently, it was reported that OK-432 was a relatively effective sclerosing agent for both lymphatic malformations and ranulas, although it has a high rate of recurrence after treating ranulas. Pingyangmycin is another reported conventional sclerosing agent for lymphatic malformations. Herein, we hypothesize that intracystic injection of pingyangmycin may be an optimal method for the treatment of ranulas.

关 键 词：舌下囊肿 注射剂 口腔医学 临床分析 

分 类 号：R739.8[医药卫生—肿瘤]